MENU
+Compare
LFCR
Stock ticker: NASDAQ
AS OF
Feb 3 closing price
Price
$7.97
Change
+$1.34 (+20.21%)
Capitalization
298.79M

LFCR Lifecore Biomedical Forecast, Technical & Fundamental Analysis

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges... Show more

LFCR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for LFCR with price predictions
Feb 02, 2026

LFCR's RSI Indicator peaks and leaves overbought zone

The 10-day RSI Oscillator for LFCR moved out of overbought territory on January 27, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 instances where the indicator moved out of the overbought zone. In of the 30 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 58 cases where LFCR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LFCR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LFCR broke above its upper Bollinger Band on January 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for LFCR entered a downward trend on January 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 16, 2026. You may want to consider a long position or call options on LFCR as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LFCR just turned positive on January 20, 2026. Looking at past instances where LFCR's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

LFCR moved above its 50-day moving average on January 14, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LFCR advanced for three days, in of 266 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LFCR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (192.308) is normal, around the industry mean (29.772). P/E Ratio (51.231) is within average values for comparable stocks, (74.035). LFCR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.041). LFCR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.029). P/S Ratio (2.155) is also within normal values, averaging (112.501).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LFCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
LFCR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a manufacturer of polymer products for food and agricultural products, medical devices and licensed partner applications

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Industrial Specialties
Address
3515 Lyman Boulevard
Phone
+1 952 368-4300
Employees
459
Web
https://www.lifecore.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FIDS26.251.38
+5.55%
FNB, Inc.
ATLCY18.260.10
+0.55%
Atlas Copco AB
FPRUY40.90N/A
N/A
Fraport AG
TUWLF0.11N/A
N/A
Tullow Oil Plc.
CUYRF72.43N/A
N/A
C Uyemura & Co Ltd.

LFCR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LFCR has been loosely correlated with AMRX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if LFCR jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
-1.96%
AMRX - LFCR
37%
Loosely correlated
+3.73%
NBIX - LFCR
36%
Loosely correlated
+1.15%
ZTS - LFCR
35%
Loosely correlated
+0.10%
KMDA - LFCR
35%
Loosely correlated
-0.61%
PAHC - LFCR
32%
Poorly correlated
-1.43%
More

Groups containing LFCR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
-1.96%
Pharmaceuticals: Generic
industry (214 stocks)
41%
Loosely correlated
+48.62%